Onderneming ContraVir Pharmaceuticals Inc OTC Bulletin Board
Aandelen
US21234W1036
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 01-01-16 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-19 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Daniel Trepanier
PRN | Corporate Officer/Principal | - | 03-10-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 15-05-13 |
Timothy Block
BRD | Director/Board Member | 69 | 26-11-13 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 27-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 688 | 0 | 0 | 94,28 % |
Aandeel B | 1 | 5 799 126 | 5 467 205 ( 94,28 %) | 0 | |
Aandeel C | 0 | 85 581 | 0 | 0 |
Bedrijfsgegevens
Hepion Pharmaceuticals, Inc.
399 Thornall Street 1st Floor
08837, Edison
+732 902 4000
http://www.hepionpharma.com![Adres ContraVir Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/15749842.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+23,41% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-15,55% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |
- Beurs
- Aandelen
- Koers HEPA
- Koers
- Onderneming ContraVir Pharmaceuticals Inc